Challenges exist in treating HPV oropharyngeal cancer patients

This article originally appeared here.
Share this content:
Challenges exist in treating HPV oropharyngeal cancer patients
Challenges exist in treating HPV oropharyngeal cancer patients

(HealthDay News) -- Key challenges have been identified for health professionals communicating the role of human papillomavirus (HPV) in oropharyngeal squamous cell cancer (OSCC), according to a study published online Oct. 28 in Head & Neck.

Rachael H. Dodd, from University College London, and colleagues interviewed 15 health professionals caring for OSCC patients. Clinicians' experiences and the challenges of talking to patients about HPV were explored in a thematic analysis.

The researchers found that there were mixed views relating to explaining the causal role of HPV. Key messages to be communicated included normalizing HPV and emphasizing the positive prognosis associated with it. Managing couples in a consultation and patients' concerns about transmission of HPV to partners were identified as challenging experiences. Some clinicians reported limitations to their knowledge about HPV and identified a need for more information and training.

"The demographic characteristics of patients with HPV-OSCC present new challenges for health professionals in terms of the questions being asked, the factors important to the patients, and their rehabilitation and treatment needs," the authors write. "Experiences among health professionals differed, suggesting a need for clinical guidance for communication about HPV in this context to ensure that patients are receiving consistent messages."

Full Text (subscription or payment may be required)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs